Pharmala Biotech Pink Sheet Forecast - Accumulation Distribution

PMBHFDelisted Stock   0.25  0.00  0.00%   
Investors can use prediction functions to forecast Pharmala Biotech's stock prices and determine the direction of Pharmala Biotech Holdings's future trends based on various well-known forecasting models. However, exclusively looking at the historical price movement is usually misleading. We recommend always using this module together with an analysis of Pharmala Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
  
Pharmala Biotech Holdings has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Pharmala Biotech is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Pharmala Biotech Holdings to determine if accumulation or reduction is taking place in the market. This value is adjusted by Pharmala Biotech trading volume to give more weight to distributions with higher volume over lower volume.
Check Pharmala Biotech VolatilityBacktest Pharmala BiotechInformation Ratio  

Pharmala Biotech Trading Date Momentum

On December 01 2024 Pharmala Biotech Holdings was traded for  0.25  at the closing time. The highest daily price throughout the period was 0.25  and the lowest price was  0.25 . There was no trading activity during the period 0.0. Lack of trading volume on 12/01/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Pharmala Biotech to competition

Pharmala Biotech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmala Biotech pink sheet to make a market-neutral strategy. Peer analysis of Pharmala Biotech could also be used in its relative valuation, which is a method of valuing Pharmala Biotech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pharmala Biotech Market Strength Events

Market strength indicators help investors to evaluate how Pharmala Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmala Biotech shares will generate the highest return on investment. By undertsting and applying Pharmala Biotech pink sheet market strength indicators, traders can identify Pharmala Biotech Holdings entry and exit signals to maximize returns.

Pharmala Biotech Risk Indicators

The analysis of Pharmala Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharmala Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmala pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Pharmala Pink Sheet

If you are still planning to invest in Pharmala Biotech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmala Biotech's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Valuation
Check real value of public entities based on technical and fundamental data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance